The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Structural Heart Diseases Device Market Research Report 2025
Synopsis
Structural heart devices comprise annuloplasty rings, heart valve balloons occluders among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.
Global Structural Heart Diseases Device market is projected to reach US$ 24600 million in 2029, increasing from US$ 13250 million in 2022, with the CAGR of 9.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Structural Heart Diseases Device market research.
The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart's structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Structural Heart Diseases Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
Segment by Type
CHD Occluder
Cardioembolic Stroke Occluder
Heart Valve
Other
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Structural Heart Diseases Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Structural heart devices comprise annuloplasty rings, heart valve balloons occluders among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.
Global Structural Heart Diseases Device market is projected to reach US$ 24600 million in 2029, increasing from US$ 13250 million in 2022, with the CAGR of 9.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Structural Heart Diseases Device market research.
The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart's structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Structural Heart Diseases Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
Segment by Type
CHD Occluder
Cardioembolic Stroke Occluder
Heart Valve
Other
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Structural Heart Diseases Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Structural Heart Diseases Device Market Overview
1.1 Product Overview and Scope of Structural Heart Diseases Device
1.2 Structural Heart Diseases Device Segment by Type
1.2.1 Global Structural Heart Diseases Device Market Value Comparison by Type (2023-2029)
1.2.2 CHD Occluder
1.2.3 Cardioembolic Stroke Occluder
1.2.4 Heart Valve
1.2.5 Other
1.3 Structural Heart Diseases Device Segment by Application
1.3.1 Global Structural Heart Diseases Device Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Structural Heart Diseases Device Market Size Estimates and Forecasts
1.4.1 Global Structural Heart Diseases Device Revenue 2018-2029
1.4.2 Global Structural Heart Diseases Device Sales 2018-2029
1.4.3 Global Structural Heart Diseases Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Structural Heart Diseases Device Market Competition by Manufacturers
2.1 Global Structural Heart Diseases Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Structural Heart Diseases Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Structural Heart Diseases Device Average Price by Manufacturers (2018-2023)
2.4 Global Structural Heart Diseases Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Structural Heart Diseases Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Structural Heart Diseases Device, Product Type & Application
2.7 Structural Heart Diseases Device Market Competitive Situation and Trends
2.7.1 Structural Heart Diseases Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Structural Heart Diseases Device Players Market Share by Revenue
2.7.3 Global Structural Heart Diseases Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Structural Heart Diseases Device Retrospective Market Scenario by Region
3.1 Global Structural Heart Diseases Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Structural Heart Diseases Device Global Structural Heart Diseases Device Sales by Region: 2018-2029
3.2.1 Global Structural Heart Diseases Device Sales by Region: 2018-2023
3.2.2 Global Structural Heart Diseases Device Sales by Region: 2024-2029
3.3 Global Structural Heart Diseases Device Global Structural Heart Diseases Device Revenue by Region: 2018-2029
3.3.1 Global Structural Heart Diseases Device Revenue by Region: 2018-2023
3.3.2 Global Structural Heart Diseases Device Revenue by Region: 2024-2029
3.4 North America Structural Heart Diseases Device Market Facts & Figures by Country
3.4.1 North America Structural Heart Diseases Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Structural Heart Diseases Device Sales by Country (2018-2029)
3.4.3 North America Structural Heart Diseases Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Structural Heart Diseases Device Market Facts & Figures by Country
3.5.1 Europe Structural Heart Diseases Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Structural Heart Diseases Device Sales by Country (2018-2029)
3.5.3 Europe Structural Heart Diseases Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Structural Heart Diseases Device Market Facts & Figures by Country
3.6.1 Asia Pacific Structural Heart Diseases Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Structural Heart Diseases Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Structural Heart Diseases Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Structural Heart Diseases Device Market Facts & Figures by Country
3.7.1 Latin America Structural Heart Diseases Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Structural Heart Diseases Device Sales by Country (2018-2029)
3.7.3 Latin America Structural Heart Diseases Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Structural Heart Diseases Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Structural Heart Diseases Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Structural Heart Diseases Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Structural Heart Diseases Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Structural Heart Diseases Device Sales by Type (2018-2029)
4.1.1 Global Structural Heart Diseases Device Sales by Type (2018-2023)
4.1.2 Global Structural Heart Diseases Device Sales by Type (2024-2029)
4.1.3 Global Structural Heart Diseases Device Sales Market Share by Type (2018-2029)
4.2 Global Structural Heart Diseases Device Revenue by Type (2018-2029)
4.2.1 Global Structural Heart Diseases Device Revenue by Type (2018-2023)
4.2.2 Global Structural Heart Diseases Device Revenue by Type (2024-2029)
4.2.3 Global Structural Heart Diseases Device Revenue Market Share by Type (2018-2029)
4.3 Global Structural Heart Diseases Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Structural Heart Diseases Device Sales by Application (2018-2029)
5.1.1 Global Structural Heart Diseases Device Sales by Application (2018-2023)
5.1.2 Global Structural Heart Diseases Device Sales by Application (2024-2029)
5.1.3 Global Structural Heart Diseases Device Sales Market Share by Application (2018-2029)
5.2 Global Structural Heart Diseases Device Revenue by Application (2018-2029)
5.2.1 Global Structural Heart Diseases Device Revenue by Application (2018-2023)
5.2.2 Global Structural Heart Diseases Device Revenue by Application (2024-2029)
5.2.3 Global Structural Heart Diseases Device Revenue Market Share by Application (2018-2029)
5.3 Global Structural Heart Diseases Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Structural Heart Diseases Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Structural Heart Diseases Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Corporation Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LifeTech Structural Heart Diseases Device Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lepu Medical Structural Heart Diseases Device Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Corporation Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Occlutech Structural Heart Diseases Device Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Corporation Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 W. L. Gore & Associates Structural Heart Diseases Device Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.6.1 Starway Corporation Information
6.6.2 Starway Description and Business Overview
6.6.3 Starway Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Starway Structural Heart Diseases Device Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Corporation Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Coherex Medical Structural Heart Diseases Device Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Corporation Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cardia Structural Heart Diseases Device Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Corporation Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 MicroPort Structural Heart Diseases Device Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
6.11 Edwards Lifesciences
6.11.1 Edwards Lifesciences Corporation Information
6.11.2 Edwards Lifesciences Structural Heart Diseases Device Description and Business Overview
6.11.3 Edwards Lifesciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Edwards Lifesciences Structural Heart Diseases Device Product Portfolio
6.11.5 Edwards Lifesciences Recent Developments/Updates
6.12 Medtronic
6.12.1 Medtronic Corporation Information
6.12.2 Medtronic Structural Heart Diseases Device Description and Business Overview
6.12.3 Medtronic Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Medtronic Structural Heart Diseases Device Product Portfolio
6.12.5 Medtronic Recent Developments/Updates
6.13 Venus Medtech
6.13.1 Venus Medtech Corporation Information
6.13.2 Venus Medtech Structural Heart Diseases Device Description and Business Overview
6.13.3 Venus Medtech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Venus Medtech Structural Heart Diseases Device Product Portfolio
6.13.5 Venus Medtech Recent Developments/Updates
6.14 Meril Life Sciences
6.14.1 Meril Life Sciences Corporation Information
6.14.2 Meril Life Sciences Structural Heart Diseases Device Description and Business Overview
6.14.3 Meril Life Sciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Meril Life Sciences Structural Heart Diseases Device Product Portfolio
6.14.5 Meril Life Sciences Recent Developments/Updates
6.15 Braile Biomedica
6.15.1 Braile Biomedica Corporation Information
6.15.2 Braile Biomedica Structural Heart Diseases Device Description and Business Overview
6.15.3 Braile Biomedica Structural Heart Diseases Device Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Braile Biomedica Structural Heart Diseases Device Product Portfolio
6.15.5 Braile Biomedica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Structural Heart Diseases Device Industry Chain Analysis
7.2 Structural Heart Diseases Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Structural Heart Diseases Device Production Mode & Process
7.4 Structural Heart Diseases Device Sales and Marketing
7.4.1 Structural Heart Diseases Device Sales Channels
7.4.2 Structural Heart Diseases Device Distributors
7.5 Structural Heart Diseases Device Customers
8 Structural Heart Diseases Device Market Dynamics
8.1 Structural Heart Diseases Device Industry Trends
8.2 Structural Heart Diseases Device Market Drivers
8.3 Structural Heart Diseases Device Market Challenges
8.4 Structural Heart Diseases Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
